Vinet L, Rouet-Benzineb P, Marniquet X, Pellegrin N, Mangin L, Louedec L, Samuel JL, Mercadier JJ. Chronic doxycycline exposure accelerates left ventricular hypertrophy and progression to heart failure in mice after thoracic aorta constriction. Am J Physiol Heart Circ Physiol 295: H352-H360, 2008. First published May 16, 2008 doi:10.1152/ajpheart.01101.2007.-Tetracycline is a powerful tool for controlling the expression of specific transgenes (TGs) in various tissues, including heart. In these mouse systems, TG expression is repressed/enhanced by adding doxycycline (Dox) to the diet. However, Dox has been shown to attenuate matrix metalloproteinase (MMP) expression and activity in various tissues, and MMP inactivation mitigates left ventricular (LV) remodeling in animal models of heart failure. Therefore, we examined the influence of Dox on LV remodeling and MMP expression in mice after transverse aortic constriction (TAC). One month after TAC, cardiac hypertrophy (99% vs. 67%) and the proportion of mice exhibiting congestive heart failure (CHF, 74% vs. 32%) were higher in the TAC ϩ Dox group than in the TAC group (P Ͻ 0.05). These differences were no longer seen 2 mo after TAC, although LV was more severely dilated in TAC ϩ Dox mice than in TAC mice (P Ͻ 0.05). One month after TAC, the increase in brain natriuretic peptide and -myosin heavy chain mRNA levels was 1.6 and 1.7 times higher, respectively, in TAC ϩ Dox mice than in TAC mice (P Ͻ 0.01). MMP-2 gelatin zymographic activity increased 1.9-and 2.4-fold in TAC and TAC ϩ Dox mice, respectively (P Ͻ 0.01 and P Ͻ 0.05 relative to respective sham-operated animals), but the difference between TAC ϩ Dox and TAC mice did not reach statistical significance. Dox did not significantly alter TAC-associated perivascular and interstitial myocardial fibrosis. These findings demonstrate that Dox accelerates the onset of cardiac hypertrophy and the progression to CHF following TAC in mice. Accordingly, care should be taken when designing and interpreting studies based on TG mouse models of LV hypertrophy using the tetracycline-regulated (tet)-on/tet-off system. pressure overload; matrix metalloproteinase; heart catheterization; echocardiography CONDITIONAL TRANSGENE (TG) expression is a powerful tool for controlling the expression of specific TGs in various tissues, including heart. Conditional TG expression using a tetracycline-regulated system (tet system), has been widely used to study the roles of numerous genes in the heart (4,7,14,22, 23,26,31,32,39,40). The main advantage of the tet system is its versatility: it offers the possibility of activating or inactivating TG expression by turning on or off a transactivator (TA) by adding or withdrawing tetracycline in the animal diet. Transactivation of a responsive promoter placed upstream of the TG of interest by tet-off (tTA) or tet-on (rtTA) is inhibited or enhanced, respectively, by tetracycline, which prevents (tTA) (8) or permits (rtTA) (11, 35) binding to the corresponding promoter. One of the tetracyclines most ...